Pathogenesis of Preeclampsia and Therapeutic Approaches Targeting the Placenta
Preeclampsia (PE) is a serious pregnancy complication, affecting about 5–7% of pregnancies worldwide and is characterized by hypertension and damage to multiple maternal organs, primarily the liver and kidneys. PE usually begins after 20 weeks’ gestation and, if left untreated, can lead to serious c...
Main Authors: | Manoj Kumar Jena, Neeta Raj Sharma, Matthew Petitt, Devika Maulik, Nihar Ranjan Nayak |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-06-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/10/6/953 |
Similar Items
-
Reduced Placental CD24 in Preterm Preeclampsia Is an Indicator for a Failure of Immune Tolerance
by: Marei Sammar, et al.
Published: (2021-07-01) -
Neutralizing Monoclonal Antibodies Reduce Human Cytomegalovirus Infection and Spread in Developing Placentas
by: Takako Tabata, et al.
Published: (2019-09-01) -
Uptake of Cerium Dioxide Nanoparticles and Impact on Viability, Differentiation and Functions of Primary Trophoblast Cells from Human Placenta
by: Margaux Nedder, et al.
Published: (2020-07-01) -
Collagen I Induces Preeclampsia-Like Symptoms by Suppressing Proliferation and Invasion of Trophoblasts
by: Yinglin Feng, et al.
Published: (2021-08-01) -
Dissecting human trophoblast cell transcriptional heterogeneity in preeclampsia using single‐cell RNA sequencing
by: Tao Zhang, et al.
Published: (2021-08-01)